Personalised modulation of ovarian response reduces OHSS risk: a randomised, controlled, assessor-blind trial comparing individualised follitropin delta versus conventional rFSH dosing in Japanese IVF/ICSI patients

Publication date: Available online 9 February 2021Source: Reproductive BioMedicine OnlineAuthor(s): Osamu Ishihara, Joan-Carles Arce, for the Japanese Follitropin Delta Phase 3 Trial (STORK) Group
Source: Reproductive BioMedicine Online - Category: Reproduction Medicine Source Type: research